Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
MPSYF similar filings
- 6 May 20 First Quarter Interim Statement
- 28 Apr 20 MorphoSys andI-Mab Announce First Patient Dosed in Phase 3 Clinical Trial of MOR202/TJ202 in r/r Multiple Myeloma in Mainland China
- 24 Apr 20 MorphoSys Appoints Roland Wandeler, Ph.D., as Chief Commercial Officer
- 23 Apr 20 Current report (foreign)
- 7 Apr 20 MorphoSys Provides Update on Impact of COVID-19 on Business Operations and Precautionary Measures
- 27 Mar 20 Current report (foreign)
- 20 Mar 20 Current report (foreign)
Filing view
External links